Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Neomed Management

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 50
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 25
Rounds per year 2.00
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 16
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Manufacturing
Summary

Neomed Management appeared to be the VC, which was created in 1997. The fund was located in Europe if to be more exact in Norway. The main department of described VC is located in the Oslo.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Neomed Management, startups are often financed by Andera Partners, Gimv, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Gimv, Legend Capital, BioMedPartners. In the next rounds fund is usually obtained by Andera Partners, OrbiMed, Gimv.

The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sonendo, Creabilis, Wilson Therapeutics.

The overall number of key employees were 3.

The typical startup value when the investment from Neomed Management is 10-50 millions dollars. The top activity for fund was in 2014. The top amount of exits for fund were in 2016. The fund is constantly included in 2-6 investment rounds annually. This Neomed Management works on 7 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 7 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Neomed Management:
Typical Co-investors
Neomed Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Neomed Management:

Funds with similar focus

Funds from Norway
Funds with similar focus located in Norway:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Oxular

Health Care
Medical
Therapeutics
$37M01 Mar 2021 Oxford, Oxfordshire, United Kingdom

JenaValve Technology

Health Care
Medical
Medical Device
$50M05 Feb 2020 Bavaria

Sonendo

Biotechnology
Health Care
Medical
$85M06 Jan 2020 California, United States

Sequana Medical

Biotechnology
Health Care
Manufacturing
Medical Device
$10M16 Oct 2018 Zurich, Zurich, Switzerland

Sonendo

Biotechnology
Health Care
Medical
$50M18 Sep 2017 California, United States

Avitide

Biotechnology
Health Care
Life Science
$12M21 Jun 2017 Lebanon, New Hampshire, United States

Axonics Modulation Technologies

Health Diagnostics
Medical
Medical Device
$14M02 May 2017 Irvine, California, United States

Sonendo

Biotechnology
Health Care
Medical
$35M13 Dec 2016 California, United States

4Tech

Manufacturing
Medical Device
$29M09 Mar 2016 Galway

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Neomed Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: